Medication info

Tseal

Prescription medicationExternal use
Ingredient · strength
Fibrinogen (Sealer Protein)›455mg / 5mLAprotinin›Strength being verifiedHuman Thrombin›Strength being verifiedCalcium Chloride Hydrate›29.4mg / 5mL
Manufacturer / importer
Korean Red Cross
Appearance
A pair of prefilled syringes with one end connected, containing a white to yellowish frozen solution.
Packaging
1 kit (2 mL)/box, 1 kit (4 mL)/box, 1 kit (10 mL)/box
Approval status
Active

MFDS item code 200410125 · Approved 2004.04.30 · Insurance code 655300160,655300250,655300411

Summary

Main use
Local hemostasis, tissue adhesion, and adjunctive treatment to suturing when existing treatment is insufficient
Who uses it
Adults · Children
Adult use
The dose and frequency of application should be determined according to the patient's condition. The amount applied varies depending on the type of surgery, the area affected, the intended method of application, and the number of applications. Use of this product must be determined by the attending physician. In clinical trials, individual doses were generally 4 ~ 20 mL. However, larger amounts may be needed in cases such as liver surgery or closure of extensive burn wounds. For initial treatment, the dose should be determined according to the anatomical structures and the wound requiring treatment, and should be sufficient to cover the entire application site. Repeat the application if necessary. However, do not reapply to areas where this product has already been applied and formed a polymerized layer, as it does not adhere well to such areas. For surface adhesion, 2 mL of product (1 mL of sealant protein solution + 1 mL of thrombin solution) in one pack is sufficient for an initial area of 10 ㎠. Depending on the specific situation or individual patient, applying the same amount of product with a spray device may be sufficient to cover a considerably larger area. To prevent excessive granulation tissue formation and allow gradual absorption of the coagulated fibrin sealant, apply as thinly as possible.
Child use
The safety and efficacy in children have not been established.

Ingredients

Importer
Korean Red Cross

Efficacy & effects

Local hemostasis, tissue adhesion, and adjunctive treatment to suturing when existing treatment is insufficient

View approved original text

This medication is used as an adjunct when symptoms cannot be controlled or are insufficient with existing treatments. It mainly aids procedures such as local hemostasis, suturing, and tissue adhesion, enhancing therapeutic effects. Therefore, it is used to complement treatment and achieve better outcomes in such situations.

How to use

Adult use

The dose and frequency of application should be determined according to the patient's condition. The amount applied varies depending on the type of surgery, the area affected, the intended method of application, and the number of applications. Use of this product must be determined by the attending physician. In clinical trials, individual doses were generally 4 ~ 20 mL. However, larger amounts may be needed in cases such as liver surgery or closure of extensive burn wounds. For initial treatment, the dose should be determined according to the anatomical structures and the wound requiring treatment, and should be sufficient to cover the entire application site. Repeat the application if necessary. However, do not reapply to areas where this product has already been applied and formed a polymerized layer, as it does not adhere well to such areas. For surface adhesion, 2 mL of product (1 mL of sealant protein solution + 1 mL of thrombin solution) in one pack is sufficient for an initial area of 10 ㎠. Depending on the specific situation or individual patient, applying the same amount of product with a spray device may be sufficient to cover a considerably larger area. To prevent excessive granulation tissue formation and allow gradual absorption of the coagulated fibrin sealant, apply as thinly as possible.

Child use

The safety and efficacy in children have not been established.

Precautions

This medication is made from human plasma and cannot completely prevent viruses or infections transmitted through blood. It is especially advisable for patients with hemophilia or those with weakened immunity to receive vaccinations such as hepatitis vaccine. When using this medication, the physician must regularly check for signs of infection. Due to the risk of infection, this medication should only be used in minimal amounts when absolutely necessary. It should not be used alone for patients with extensive and rapid bleeding, and cannot replace skin sutures for closing surgical sites. It should not be administered to patients with allergies to this medication or its components. Injecting it into the bloodstream can lead to serious side effects such as thrombosis or embolism; hence it must never be administered intravenously. Patients with allergies or sensitivity to medications should use this medication with caution, and those who have previously used protamine components are recommended to take antihistamines. This medication can rarely cause allergic reactions such as venous swelling, itching, shortness of breath, hives, hypotension, nausea, rash, anxiety, tachycardia, vomiting, pruritus, erythema, sensory disturbances, hypotension, hematoma, paresthesia, chest tightness, pain, elevated temperature, limb pain, queasiness, treatment failure, procedural pain, seroma, blood and lymphatic abnormalities (increased fibrin degradation products), post-surgical wound infections, and edema. In particular, there is a risk of severe anaphylaxis (acute allergic reaction) in patients who have been sensitized to protamine or have used it multiple times. Improper administration into the bloodstream can lead to dangerous conditions such as thromboembolism or disseminated intravascular coagulation. This medication should be applied only to wound areas and must never be injected into the bloodstream, and care must be taken to avoid air embolism or tissue damage when using high-pressure gas to spray. The manufacturer's recommended pressure and distance should be observed during spraying, and blood pressure, pulse, oxygen saturation, etc. of the spray area should be closely monitored. Before using this medication, care should be taken to avoid contact of body parts other than the application site with this medication, and it should be confirmed that the product is completely thawed and properly mixed just before use. The safety of this medication for pregnant or breastfeeding women has not been sufficiently confirmed, so it should only be used when absolutely necessary. Applying it too thickly can reduce the drug's effectiveness and impede wound healing, so it should be applied thinly and any excess medication should be removed as much as possible. This medication must be stored frozen, and once thawed, it must not be refrozen or stored in a refrigerator. It should be stored protected from light until use, and must be used within the specified time after thawing.

Side effects

Hypersensitivity, allergic reactions, angioedema, burning sensation and tenderness at the injection site, bradycardia, bronchospasm, chills, difficulty breathing, transient erythema, systemic hives, headache, urticaria, hypotension, drowsiness, nausea, rash, anxiety, tachycardia, chest tightness, paresthesia, vomiting, wheezing, thromboembolism, disseminated intravascular coagulation, post-surgical wound infection, increase in fibrin degradation products, hypersensitivity, anaphylactic reactions, anaphylactic shock, sensory disturbances, bronchospasm, wheezing, itching, erythema, sensory impairment, axillary venous thrombosis, hematoma, arterial embolism, air embolism, cerebral arterial embolism, cerebral infarction, nausea, bowel obstruction, rash, urticaria, treatment failure, limb pain, pain, elevated body temperature, serum tumor, angioedema, injection site irritation, chest discomfort, chills, headache, drowsiness, anxiety, vomiting, local skin reactions

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to light and should be kept in a container that does not allow light to enter. Additionally, it is important to store it frozen at or below -20 degrees Celsius to maintain its effectiveness.

Appearance and packaging

Appearance

A pair of prefilled syringes with one end connected, containing a white to yellowish frozen solution.

Package unit

1 kit (2 mL)/box, 1 kit (4 mL)/box, 1 kit (10 mL)/box

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.